{
  "meta": {
    "title": "55_Antimigraine_And_Antigout_Drugs",
    "url": "https://brainandscalpel.vercel.app/55-antimigraine-and-antigout-drugs-fa2a8ba9.html",
    "scrapedAt": "2025-11-30T12:34:35.503Z"
  },
  "questions": [
    {
      "text": "Which of the following receptors is a ligand-gated ion channel?",
      "choices": [
        {
          "id": 1,
          "text": "5-HT 1 receptor"
        },
        {
          "id": 2,
          "text": "5-HT 2 receptor"
        },
        {
          "id": 3,
          "text": "5-HT 3 receptor"
        },
        {
          "id": 4,
          "text": "5-HT 4-7 receptors"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The<strong> 5-HT<sub>3</sub> receptor</strong>&nbsp;is a&nbsp;<strong>ligand-gated ion channel receptor</strong>. It rapidly depolarizes nerve endings by opening the cation channels located within the receptor.</p>\n<p>The 5-HT<sub>3</sub> receptors are located in the GI tract (vagal &amp; splanchnic afferents) and the brain (nucleus tractus solitarius &amp; area postrema) and are involved in the emetic response. Hence&nbsp;5-HT3 receptor antagonists like&nbsp;ondansetron, dolasetron etc are used as antiemetics.</p>\n<p>All other 5-HT receptors are G-protein-coupled receptors.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7439",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is false regarding triptans?",
      "choices": [
        {
          "id": 1,
          "text": "They are 5HT 1B/1D agonists"
        },
        {
          "id": 2,
          "text": "No action on adrenergic or cholinergic or dopaminergic receptors"
        },
        {
          "id": 3,
          "text": "Sumatriptan is safe in pregnancy"
        },
        {
          "id": 4,
          "text": "They are used for prophylaxis of migraine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Triptans</strong> are not used in prophylaxis of migraine. They are indicated in the <strong>management of acute attacks</strong> of migraine.</p>\n<p>Drugs used in prophylaxis of migraine are :</p>\n<ul>\n<li>Beta-blocker - Propranolol, metoprolol</li>\n<li>Antidepressant - Amitriptyline, nortriptyline</li>\n<li>Anticonvulsant - Topiramate, valproate</li>\n<li>Serotonergic drug - Pizotifen</li>\n<li>Antihistamine - Flunarizine</li>\n<li>Angiotensin receptor blocker - candesartan</li>\n</ul>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7447",
      "difficulty": "medium"
    },
    {
      "text": "A 25-year-old patient presented to the ER with an acute attack of migraine. You decide to administer a long-acting triptan. Which among the following do you choose?",
      "choices": [
        {
          "id": 1,
          "text": "Sumatriptan"
        },
        {
          "id": 2,
          "text": "Rizatriptan"
        },
        {
          "id": 3,
          "text": "Frovatriptan"
        },
        {
          "id": 4,
          "text": "Zolmitriptan"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Frovatriptan</strong> is a <strong>long-acting</strong> triptan among&nbsp;other triptans.</p>\n<p><strong>Headache recurrences</strong> in an attack are <strong>less</strong> with longer-acting triptans like frovatriptan and naratriptan but onset of action may be slow.</p><hr><h3>Related Pearl: Triptans - 5HT 1B/1D agonists</h3><p>Few important properties of triptans:</p>\n<ul>\n<li><strong>Longest </strong>acting triptan: <strong>Frovatriptan</strong></li>\n<li><strong>Fastest</strong> (Oral) acting triptan: <strong>Rizatriptan</strong></li>\n<li><strong>Least bioavailability</strong> (Oral): <strong>Sumatriptan</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7449",
      "difficulty": "medium"
    },
    {
      "text": "A patient of migraine has come to the OPD for follow up. She tells you that she gets very nauseous during the attacks and is not being able to take the oral drug. You decide to prescribe an intranasal formulation instead. Which of the following antimigraine agents will you not choose?",
      "choices": [
        {
          "id": 1,
          "text": "Dihydroergotamine"
        },
        {
          "id": 2,
          "text": "Sumatriptan"
        },
        {
          "id": 3,
          "text": "Zolmitriptan"
        },
        {
          "id": 4,
          "text": "Naratriptan"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Naratriptan</strong> is not available for intranasal administration. It is <strong>available only</strong> for <strong>oral</strong> administration.&nbsp;</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4786",
      "difficulty": "hard"
    },
    {
      "text": "After the administration of a drug for an acute attack of migraine, a patient developed nausea and vomiting. She also developed tingling and numbness at the tips of her fingers that eventually turned blue. Which of the following is the most likely drug implicated?",
      "choices": [
        {
          "id": 1,
          "text": "Dihydroergotamine"
        },
        {
          "id": 2,
          "text": "Sumatriptan"
        },
        {
          "id": 3,
          "text": "Butorphanol"
        },
        {
          "id": 4,
          "text": "Aspirin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Nausea and vomiting, as well as tingling and numbness (paresthesia), are common adverse effects of <strong>dihydroergotamine.</strong></p>\n<p>The numbness progressing to bluish discolouration of the fingers are the initial signs of occlusion. It can eventually lead to <strong>gangrene</strong> if left untreated. This is a rare adverse effect of dihydroergotamine.</p>\n<p>Contraindications for ergotamine:&nbsp;</p>\n<ul>\n<li>Peripheral vascular disease</li>\n<li>Coronary artery disease</li>\n<li>Uncontrolled hypertension</li>\n<li>Fever and/or sepsis</li>\n<li>Pregnancy</li>\n<li>Within 24 hours of using triptans</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4788",
      "difficulty": "easy"
    },
    {
      "text": "A patient has just been diagnosed with migraine. Which of the following drugs can you prescribe for prophylaxis?",
      "choices": [
        {
          "id": 1,
          "text": "Sumatriptan"
        },
        {
          "id": 2,
          "text": "Ergotamine"
        },
        {
          "id": 3,
          "text": "Domperidone"
        },
        {
          "id": 4,
          "text": "Topiramate"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Topiramate </strong>is used in the<strong> prophylaxis </strong>of <strong>migraine.</strong>&nbsp;Long-term&nbsp;use of topiramate can cause weight loss.</p>\n<p>The drugs that have been approved by the FDA for the preventive treatment of migraine include:</p>\n<ul>\n<li>Propranolol</li>\n<li>Timolol</li>\n<li>Sodium valproate</li>\n<li>Topiramate</li>\n</ul>\n<p>Options A and B - <strong>Sumatriptan</strong>, a 5HT<sub>1B/1D</sub> agonist is a first-line agent for&nbsp;the termination of acute attacks. <strong>Ergotamines</strong> are also used in the <strong>termination of acute attacks</strong>.&nbsp;</p>\n<p>Option C - <strong>Domperidone</strong> is indicated as an <strong>adjuvant</strong> in acute attacks. Acute attacks are associated with gastric stasis and an increased incidence of nausea and vomiting. It&nbsp;is helpful in <strong>reducing gastrointestinal effects</strong>. It can also increase gastrointestinal absorption of other antimigraine agents that are not absorbed due to gastric stasis.&nbsp;</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4784",
      "difficulty": "easy"
    },
    {
      "text": "What is the mechanism of action of colchicine?",
      "choices": [
        {
          "id": 1,
          "text": "Inhibits synthesis of uric acid"
        },
        {
          "id": 2,
          "text": "Promotes excretion of uric acid"
        },
        {
          "id": 3,
          "text": "Inhibits xanthine oxidase enzyme"
        },
        {
          "id": 4,
          "text": "Binds to tubulin and inhibits granulocyte migration"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Colchicine acts by binding to tubulin and inhibits granulocyte migration.</p>\n<p>Colchicine produces its anti-inflammatory effects by binding to the intracellular protein tubulin. This <strong>prevents</strong> the&nbsp;<strong>polymerization of tubulin </strong>into microtubules&nbsp;which is necessary for&nbsp;leukocyte migration and phagocytosis. Inhibition of microtubule formation prevents granulocyte migration and also <strong>arrests cell division at G<sub>1&nbsp;</sub></strong>phase.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7456",
      "difficulty": "medium"
    },
    {
      "text": "Which one of the following drugs inhibits neutrophil recruitment?",
      "choices": [
        {
          "id": 1,
          "text": "Montelukast"
        },
        {
          "id": 2,
          "text": "Sodium cromolyn"
        },
        {
          "id": 3,
          "text": "Colchicine"
        },
        {
          "id": 4,
          "text": "Febuxostat"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Colchicine</strong> inhibits neutrophil (granulocyte) recruitment.</p>\n<p>Colchicine acts by preventing the polymerisation of microtubules by binding to tubulin. This reduces neutrophil recruitment to inflamed tissue and also decreases the secretion of chemotactic factors by activated neutrophils, thus reducing the inflammatory response overall.</p>\n<p>Colchicine is used in&nbsp;<strong>gout </strong>and <strong>Mediterranean fever. </strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7549",
      "difficulty": "medium"
    },
    {
      "text": "A patient with chronic tophaceous gout was prescribed sulfinpyrazone. What is the mechanism of action of this drug?",
      "choices": [
        {
          "id": 1,
          "text": "Inhibits formation of uric acid"
        },
        {
          "id": 2,
          "text": "Promotes excretion of uric acid"
        },
        {
          "id": 3,
          "text": "Inhibits xanthine oxidase enzyme"
        },
        {
          "id": 4,
          "text": "Inhibits cyclooxygenase enzyme"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Sulfinpyrazone</strong> is a <strong>uricosuric agent</strong> that promotes excretion of uric acid. It is used to decrease the body pool of urate in patients with gout. They act by <strong>inhibiting</strong> the <strong>organic anion transporter</strong> that is involved in uric acid reabsorption in renal tubules.</p>\n<p>Uricosuric agents used in gout are:</p>\n<ul>\n<li>Probenecid</li>\n<li>Sulfinpyrazone</li>\n<li>Benzbromarone</li>\n<li>Lesinurad</li>\n</ul>\n<p><strong>Uricosuric therapy</strong> should be initiated in gouty patients with <strong>underexcretion of uric acid</strong> and when allopurinol or febuxostat is contraindicated or when <strong>tophi</strong> are <strong>present.</strong> Therapy should not be started until 2&ndash;3 weeks after an acute attack.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7458",
      "difficulty": "easy"
    },
    {
      "text": "A middle-aged obese man has presented to the OPD with acute pain around his left first metatarsophalangeal joint. He has a history of similar episodes in the past. X-ray is given below. Which drug is commonly used as initial treatment for this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Aspirin"
        },
        {
          "id": 2,
          "text": "Indomethacin"
        },
        {
          "id": 3,
          "text": "Allopurinol"
        },
        {
          "id": 4,
          "text": "Colchicine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given scenario and the X-ray showing Martel's sign point towards a diagnosis of <strong>acute on chronic presentation of gout</strong>. <strong>Indomethacin</strong> is commonly used in the initial treatment of gout.</p>\n<p>In addition to <strong>inhibiting prostaglandin synthesis</strong>, indomethacin and other NSAIDs also <strong>inhibit urate crystal phagocytosis</strong>.</p>\n<p>Option A - Aspirin is not used because it causes renal retention of uric acid at low doses. It is uricosuric only at higher doses that are poorly tolerated.</p>\n<p>Option C - Allopurinol is used for prophylaxis of gout.</p>\n<p>Option D - NSAIDs are selected over colchicine because of troublesome diarrhea associated with colchicine.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/7a063ae8e64e4e7bb4bc1d04c6362f44.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7459",
      "difficulty": "medium"
    },
    {
      "text": "A patient undergoing chemotherapy was diagnosed with tumour lysis syndrome. She was administered rasburicase. Which group does this drug belong to?",
      "choices": [
        {
          "id": 1,
          "text": "Recombinant xanthine oxidase"
        },
        {
          "id": 2,
          "text": "Recombinant urate oxidase"
        },
        {
          "id": 3,
          "text": "Inhibitor of xanthine oxidase"
        },
        {
          "id": 4,
          "text": "Inhibitor of uric acid oxidase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Rasburicase</strong> is a<strong> recombinant urate oxidase</strong> which converts uric acid into soluble and inactive allantoin.<strong>&nbsp;</strong>It is <strong>more</strong> <strong>effective</strong> in reducing the urate level <strong>than allopurinol</strong>.</p>\n<p>Recombinant uric acid oxidase is available as rasburicase and pegloticase<strong>. </strong>It is produced by genetically modified <em>Saccharomyces cerevisiae </em>strain. They&nbsp;are <strong>indicated</strong> in gout only for <strong>chronic refractory gout.&nbsp;</strong>It is primarily indicated for hyperuricemia associated with <strong>tumor lysis syndrome</strong>.</p>\n<p>Pegloticase is a recombinant pegylated uric acid oxidase that is indicated for treatment of severe, treatment-refractory, chronic gout and also prophylaxis of gout.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7460",
      "difficulty": "medium"
    },
    {
      "text": "You have prescribed the first-line urate-lowering drug to a patient with chronic gout. Which of the following is true about this drug?",
      "choices": [
        {
          "id": 1,
          "text": "Pyrimidine antimetabolite"
        },
        {
          "id": 2,
          "text": "Inhibitor of neutrophil recruitment"
        },
        {
          "id": 3,
          "text": "Uricosuric drug"
        },
        {
          "id": 4,
          "text": "Xanthine oxidase inhibitor"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Allopurinol </strong>is recommended as the <strong>first-line</strong> urate-lowering agent in all patients with gout. It is a<strong> purine antimetabolite </strong>and an<strong> inhibitor of xanthine oxidase </strong>enzyme.</p>\n<p>It prevents the conversion of hypoxanthine and xanthine to uric acid <strong>reducing plasma uric acid</strong> levels. Allopurinol is also a substrate for xanthine oxidase. The <strong>metabolite </strong>of allopurinol called<strong> oxypurinol</strong> is a <strong>non-competitive inhibitor </strong>of xanthine oxidase.  </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7461",
      "difficulty": "easy"
    },
    {
      "text": "A patient was on treatment with indomethacin for gout. You decide to add a non-purine xanthine oxidase inhibitor to his treatment plan. Which of the following will you prescribe?",
      "choices": [
        {
          "id": 1,
          "text": "Allopurinol"
        },
        {
          "id": 2,
          "text": "Febuxostat"
        },
        {
          "id": 3,
          "text": "Either a or b"
        },
        {
          "id": 4,
          "text": "Sulfinpyrazone"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Febuxostat</strong> is a<strong> non-purine xanthine oxidase inhibitor</strong> that is indicated for reducing hyperuricemia in chronic gout. Both allopurinol and febuxostat can be used as first line agents but since the question mentions a non-purine inhibitor is chosen, febuxostat is the answer.</p>\n<p>Option A - Allopurinol is a purine xanthine oxidase inhibitor.</p>\n<p>Option D - Sulfinpyrazone is a uricosuric agent.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7462",
      "difficulty": "medium"
    },
    {
      "text": "A patient, who is a known case of gout on treatment with allopurinol, comes to the OPD for follow up. His serum uric acid level is 11 mg/dl. You add lesinurad to his treatment regime for adequate disease control. Which group does this drug belong to?",
      "choices": [
        {
          "id": 1,
          "text": "Uric acid synthesis inhibitor"
        },
        {
          "id": 2,
          "text": "Uricosuric agent"
        },
        {
          "id": 3,
          "text": "Xanthine oxidase inhibitor"
        },
        {
          "id": 4,
          "text": "Recombinant xanthine oxidase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Lesinurad is a<strong> uricosuric agent.</strong></p>\n<p>It is a<strong> URAT1 inhibitor </strong>indicated in combination with a xanthine oxidase inhibitor for the <strong>treatment</strong> of<strong> hyperuricemia </strong>associated with gout. By inhibiting URAT1, it increases the urinary excretion of uric acid.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8261",
      "difficulty": "medium"
    },
    {
      "text": "What is pegloticase used for?",
      "choices": [
        {
          "id": 1,
          "text": "Chronic gout"
        },
        {
          "id": 2,
          "text": "Rheumatoid arthritis"
        },
        {
          "id": 3,
          "text": "Psoriatric arthritis"
        },
        {
          "id": 4,
          "text": "Paralytic ileus"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Pegloticase</strong> is used in the treatment of <strong>chronic gout.</strong></p>\n<div class=\"page\" title=\"Page 711\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Pegloticase is a <strong>pegylated uricase</strong> (urate oxidase). It catalyzes the enzymatic oxidation of <strong>uric acid into allantoin</strong>, which is a more soluble and inactive metabolite.</p>\n<p>It is used in the treatment of <strong>severe</strong>,&nbsp;<strong>refractory chronic gout</strong> or in cases where other urate-lowering therapies are contraindicated.</p>\n</div>\n</div>\n</div>\n</div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0130",
      "difficulty": "easy"
    },
    {
      "text": "An elderly woman on treatment for migraine presents with chest pain. She has a previous history of angina/MI. Which of the following mechanism of the prescribed drug for migraine might have caused this presentation?",
      "choices": [
        {
          "id": 1,
          "text": "5-HT antagonist"
        },
        {
          "id": 2,
          "text": "5-HT agonist"
        },
        {
          "id": 3,
          "text": "Calcium Channel Blocker action"
        },
        {
          "id": 4,
          "text": "Nitric oxide mediated vasodilation"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The patient may have been given <strong>sumatriptan,</strong> a <strong>5-HT<sub>1b/1d </sub> receptor agonist</strong> which causes <strong>vasoconstriction</strong> and used in migraine. Thus, sumatriptan will <strong>worsen angina</strong> by causing coronary vasoconstriction.</p>\n<p>Angina will be worsened if the O<sub>2</sub> demand of the heart is increased or there is reduced blood flow to the already ischemic areas.</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6615",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is correct about the drugs used in gout?<div class='question-desc-html'><ol>\n<li>Aspirin is not used as it decreases the uric acid secretion</li>\n<li>Diclofenac is used as it concentrates in the joint</li>\n<li>Indomethacin is used as it acts by multiple pathways</li>\n<li>Aspirin is used as it is most powerful NSAID</li>\n<li>Indomethacin is not used as it is not very effective</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2 & 3"
        },
        {
          "id": 2,
          "text": "2, 3 & 4"
        },
        {
          "id": 3,
          "text": "1, 2 & 5"
        },
        {
          "id": 4,
          "text": "3 & 4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><span data-preserver-spaces=\"true\">Gout is a metabolic disease associated with hyperuricemia.</span></p>\n<p><span data-preserver-spaces=\"true\">The <strong>drug of choice</strong> in an acute attack of gout is&nbsp;<strong>NSAIDs&nbsp;</strong>(non-steroidal anti-inflammatory drugs) like&nbsp;<strong>indomethacin&nbsp;</strong>or the drug&nbsp;colchicine.<strong>&nbsp;</strong>Colchicine is poorly tolerated and should&nbsp;not&nbsp;be used in&nbsp;elderly&nbsp;patients&nbsp;with&nbsp;chronic kidney&nbsp;disease.</span></p>\n<p><span data-preserver-spaces=\"true\">Indomethacin is commonly used in the initial treatment of gout. In addition to inhibiting prostaglandin synthase, indomethacin and other NSAIDs also inhibit urate crystal phagocytosis</span></p>\n<p><span data-preserver-spaces=\"true\"><strong>Intraarticular&nbsp;steroids&nbsp;</strong>like&nbsp;<strong>triamcinolone&nbsp;</strong>or&nbsp;<strong>methylprednisolone&nbsp;</strong>can also be given.</span></p>\n<p><span data-preserver-spaces=\"true\"><strong>Aspirin </strong>is<strong> not used</strong> because it <strong>causes renal retention of uric acid</strong> at low doses. It is uricosuric only at higher doses that are poorly tolerated.</span></p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Drugs precipitating Gout</h3><p>Drugs that precipitate gout are-</p>\n<p><strong>C</strong>yclosporine or cancer drugs<br /><strong>A</strong>spirin (low dose)<br /><strong>N</strong>iacin<br /><strong>T</strong>hiazide<br /><strong>L</strong>asix (furosemide)<br /><strong>E</strong>thambutol<br /><strong>A</strong>lcohol<br /><strong>P</strong>yrazinamide</p>\n<p>Mnemonic for drugs precipitating gout is '<strong>CANT LEAP</strong>'</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6678",
      "difficulty": "medium"
    },
    {
      "text": "A patient was prescribed erenumab-aooe for the prophylaxis of migraine. What is the mechanism of action of this drug?",
      "choices": [
        {
          "id": 1,
          "text": "Parathyroid hormone related protein (PTHrP) receptor agonist"
        },
        {
          "id": 2,
          "text": "Parathyroid hormone related protein (PTHrP) receptor antagonist"
        },
        {
          "id": 3,
          "text": "Calcitonin gene related protein (CGRP) receptor agonist"
        },
        {
          "id": 4,
          "text": "Calcitonin gene related protein (CGRP) receptor antagonist"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Erenumab-aooe </strong>is a<strong> calcitonin gene related protein </strong>(CGRP) <strong>receptor antagonist </strong>approved for the<strong> prophylaxis of migraine.&nbsp;</strong></p>\n<p>The pathology of migraine is not completely understood but it includes activation of trigeminal ganglion nociceptive neurons and the subsequent <strong>release of CGRP</strong> from fibers associated with meningeal vessels. This is believed to <strong>mediate vasodilation</strong> and <strong>mast cell degranulation</strong>. Thus, CGRP is involved in the development and maintenance of persistent pain, central sensitization and allodynia, which are events characteristic of migraine pathology.&nbsp;</p>\n<p id=\"P12\" class=\"p p-first\">Blockage of CGRP receptors by CGRP receptor antagonists, causes inhibition of the inflammatory and nociceptive effects of CGRP at multiple sites within the peripheral and central nervous systems that are implicated in the underlying pathology of migraine.</p>\n<p class=\"p p-first\"><strong>Monoclonal antibodies</strong> that <strong>directly inhibit CGRP</strong> have also been developed. These include:</p>\n<ul>\n<li class=\"p p-first\">Fremanezumab</li>\n<li class=\"p p-first\">Galcanezumab</li>\n</ul><p>Note:</p>\n<p>The FDA has recently approved <strong>Atogepant</strong>, a calcitonin gene-related peptide (CGRP) receptor antagonist for the preventive treatment of episodic migraine in adults.&nbsp;The recommended dosage is 10 mg, 30 mg, or 60 mg orally once daily. In severe renal impairment or end-stage renal disease it is 10 mg once daily.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4353",
      "difficulty": "medium"
    }
  ]
}